Re-evaluating natural resistance to herpes simplex virus type 1.
about
ICP0 dismantles microtubule networks in herpes simplex virus-infected cellsRe-evaluating the role of natural killer cells in innate resistance to herpes simplex virus type 1Macrophages and cytokines in the early defence against herpes simplex virusInhibition of MHC class I is a virulence factor in herpes simplex virus infection of mice.To Infection and Beyond: The Multi-Pronged Anti-Cancer Mechanisms of Oncolytic VirusesHerpes simplex epithelial and stromal keratitis: an epidemiologic updateHerpes simplex virus-1 induces expression of a novel MxA isoform that enhances viral replication.Green fluorescent protein is a quantitative reporter of gene expression in individual eukaryotic cells.The amino terminus of herpes simplex virus 1 glycoprotein K is required for virion entry via the paired immunoglobulin-like type-2 receptor alphaICP0 antagonizes Stat 1-dependent repression of herpes simplex virus: implications for the regulation of viral latency.Innate and adaptive immune responses to herpes simplex virusHerpes simplex virus 1 ICP0 phosphorylation site mutants are attenuated for viral replication and impaired for explant-induced reactivation.Construction and characterization of a herpes simplex virus type I recombinant expressing green fluorescent protein: acute phase replication and reactivation in miceVon Willebrand Factor Gene Variants Associate with Herpes simplex Encephalitis.A herpes simplex virus 1 (McKrae) mutant lacking the glycoprotein K gene is unable to infect via neuronal axons and egress from neuronal cell bodies.The case for immunomodulatory approaches in treating HSV encephalitis.Human cytomegalovirus (CMV) in Africa: a neglected but important pathogenPre-clinical Assessment of C134, a Chimeric Oncolytic Herpes Simplex Virus, in Mice and Non-human Primates.Susceptibility of BALB/c-nu/nu mice and BALB/c mice to equine herpesvirus 9 infection.The herpes simplex virus type 1 (HSV-1) glycoprotein K(gK) is essential for viral corneal spread and neuroinvasiveness.Role of a cdk5-associated protein, p35, in herpes simplex virus type 1 replication in vivo.A novel adjuvant, the general opioid antagonist naloxone, elicits a robust cellular immune response for a DNA vaccine.Efficacy of HER2 retargeted herpes simplex virus as therapy for high-grade glioma in immunocompetent mice.Withdrawal from morphine reduces cell-mediated immunity against herpes simplex virus generated by natural immunization.The pUL37 tegument protein guides alpha-herpesvirus retrograde axonal transport to promote neuroinvasion.
P2860
Q21136348-98D9563C-C2A7-4F38-9FBB-537D2AA72933Q24814677-25AB8869-B0AD-4EA1-814F-28B1250D5787Q24815062-CA37C472-5546-4380-A672-5DCECC1403E2Q24817190-5FD8238C-0BFA-4D57-9C68-688C2FC0F56DQ26767212-677249EA-DD5B-4446-8278-46A4B9E4430EQ26853504-AAAFD998-337C-488B-84B2-1BD9B9CE2E59Q33922329-5EC7703D-7231-41D8-BF29-3039734F9E28Q33984267-11C13CC5-2D05-45C8-AA2F-BA3EEB4AC180Q34321839-39C76C6A-F043-4AF8-8449-D980DF6134F2Q35013167-C459ABDE-8E61-4B54-B49C-BA0CAF1CE040Q35260078-AB3885B9-DE9A-4B7A-9D1C-186F66ECDD4CQ35531602-62A91A13-CE75-4CEC-8773-516A22DF4B01Q35989192-2C4E2538-80CC-4E8D-965F-9EE0699F11A2Q36029291-762370A2-7A21-4E13-8318-D287C704FFABQ36145885-9DC75A07-C1D5-4F92-A7C3-5B2F11627319Q37091308-9A417734-7B07-491D-8701-E46A3E8CD363Q37141399-5A1582F3-71C1-4CD7-9ADB-311775D2EDDDQ37718569-A2396448-9107-4B48-98C1-66AFD28E1EB2Q39134327-DB9C3639-3401-4BB4-BC79-D5B6E553C0A9Q39969943-68973BCF-B7F4-4A93-948C-72C53F3A67E4Q42377986-E59C8166-74C6-468F-B421-9B8CE15EC87CQ44341358-DCBF6D25-3C12-4844-8777-EA3888765637Q45354666-3D48CC7E-4EF0-4DF6-B6BE-B840B98CE624Q45358803-6ACE6925-EEB6-444B-ACD9-A0F6C7C14CA2Q47319444-BB6D6DE5-E5DB-4055-A7FB-581FBE2D36D1
P2860
Re-evaluating natural resistance to herpes simplex virus type 1.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Re-evaluating natural resistance to herpes simplex virus type 1.
@en
Re-evaluating natural resistance to herpes simplex virus type 1.
@nl
type
label
Re-evaluating natural resistance to herpes simplex virus type 1.
@en
Re-evaluating natural resistance to herpes simplex virus type 1.
@nl
prefLabel
Re-evaluating natural resistance to herpes simplex virus type 1.
@en
Re-evaluating natural resistance to herpes simplex virus type 1.
@nl
P2093
P2860
P1433
P1476
Re-evaluating natural resistance to herpes simplex virus type 1.
@en
P2093
Bryan M Gebhardt
John W Balliet
William P Halford
P2860
P304
10086-10095
P356
10.1128/JVI.78.18.10086-10095.2004
P407
P577
2004-09-01T00:00:00Z